Northland Bio’s HGF naked plasmid therapy for severe lower limb ischemia begins commercial distribution in China On October 14, 2026, Yaohai Bio-Pharma held a ceremony
Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at TIDES Europe
Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at Festival of
Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at CPHI Milan
Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at BioProcess International
Yaohai Bio-Pharma to Showcase End-to-End Microbial CRDMO Solutions at BIO International Convention 2026 in San Diego Yaohai Bio-Pharma will attend the upcoming BIO International Convention
